GVR Report cover Gynecological Devices Market Size, Share & Trends Report

Gynecological Devices Market Size, Share & Trends Analysis Report By Product (Surgical Devices, Handheld Instruments), By End Use (Hospitals & Clinics, ASCs), By Region, And Segment Forecasts, 2023 - 2030

  • Report ID: 978-1-68038-780-3
  • Number of Pages: 210
  • Format: Electronic (PDF)
  • Historical Range: 2017 - 2021
  • Industry: Healthcare

Report Overview

The global gynecological devices market size was valued at USD 9.3 billion in 2022 and is anticipated to grow at a CAGR of 8.64% from 2023 to 2030. The advancement in the gynecological devices that aid in improving the efficiency of the minimally invasive technique for surgeries and the development of advanced imaging devices, such as 3D endoscopes, are expected to drive the growth of the industry. For instance, in July 2021, the first gynecological procedure was performed in Panama with the aid of the Hugo Robotic-Assisted Surgery (RAS) system developed by Medtronic Plc.

North America gynecological devices market size and growth rate, 2023 - 2030

The growing prevalence of gynecological disorders is expected to propel the market growth during the forecast period. Endometriosis, Polycystic Ovary Syndrome (PCOS), adenomyosis, and uterine fibroids are the most common conditions. According to an article published in the Frontiers Journal in 2021, PCOS population-based pool prevalence is around 5 to 9% globally. Hence, the growing prevalence of these conditions is leading to a rising number of regular check-ups and surgical procedures. For instance, as per the Office on Women's Health (OWH), in the U.S., around 500,000 women opt for hysterectomy, which is the second-most common surgery performed among females.

Moreover, the increasing volume of surgical procedures, such as female sterilization, ablation, endoscopy, and laparoscopy, and increasing usage of disposable products are expected to boost the product demand. The rising adoption of advanced and innovative technologies is also expected to propel industry growth. For instance, in March 2022, Endoluxe, a California-based company, launched Endoluxe eVS, HD wireless endoscopic camera equipped with TowerTech for gynecological, urological, ENT, orthopedics, and general surgery. The market is highly regulated to enhance and ensure the safety of the devices. For instance, gynecological devices are classified under classes I, II, and III by the U.S. FDA.

COVID-19 gynecological devices market impact: 10.3% growth from 2020 to 2021

Pandemic Impact

Post COVID Outlook

The pandemic has drastically affected the industry owing to the cancellation and postponement of elective surgeries. For instance, as per the article published in Virtual Health Library, around 28 million surgeries were canceled or postponed during the pandemic. In Brazil, around a 33.4% decrease in surgical procedures was reported after the postponement of non-essential and elective surgeries by the National Health Agency (ANS) and National Health Surveillance Agency

The industry is expected to witness lucrative growth in the near future owing to the adoption of advanced technologies and an increasing number of surgeries globally. For instance, Boston Scientific Corp. reported an 18% increase in consolidated net sales for endoscopy and a 13.3% increase in the urology and pelvic health segment

The industry was highly impacted by the decline in the number of visits for gynecological conditions. For instance, in 2020, around 90% and 77% decrease in visits for gynecological problems from 2019 was reported by Allegheny Health and John Hopkins, respectively

The pandemic accelerated the digital transformation in the healthcare sector including the digitalization of medical devices. The use of AI and ML will increase the management of gynecological disorders using gynecological devices. For instance, in November 2021, Hologic, Inc. launched the Global Endometrial Ablation (GEA) device, NovaSure V5 at the American Association of Gynecologic Laparoscopists (AAGL). The device is updated with EndoForm technology and can accommodate a range of anatomical and cervical canal variabilities

 

The Asia Pacific Association for Gynecologic Endoscopy and Minimally Invasive Therapy regulates the use of endoscopic devices for gynecology in the Asia Pacific region. A rise in the number of unintended pregnancies during the pandemic resulted in unsafe abortions or some gynecological conditions. This has led to an increase in gynecological surgical volumes globally. According to the United Nations, around 60% of pregnancies globally are unintended and around 45% of unintended pregnancies lead to unsafe abortion.

Product Insights

Based on products, the industry has been segmented into surgical devices, gynecological imaging devices, and handheld instruments. The surgical devices segment dominated the industry in 2022 and accounted for the largest share of 50.01% of the global revenue. The segment is expected to witness the highest growth with a CAGR of 9.10% over the forecast period. High usage of female contraceptives and endoscopic devices is anticipated to support the dominance of the segment throughout the forecast period. For instance, CooperSurgical reported a 26% increase in net sales for office and surgical products used by obstetricians/gynecologists in the hospitals. Moreover, the demand for easily autoclavable and highly durable surgical instruments has been rising due to the increasing surgical procedure volumes globally.

Rising awareness regarding birth control devices and surgeries is also estimated to boost segment growth. In addition, the growing number of female sterilization procedures is playing a vital role in the development of the market. As per the Contraceptive Use by Method 2019, by United Nations, around 842 million women among 1.9 million women of reproductive age use modern methods of contraception globally. Approximately 11.5% and 8.4% of women of reproductive age use female sterilization and Intrauterine Devices (IUDs), respectively as contraceptive methods, which is highest among other contraceptives.

The diagnostic imaging systems segment is expected to witness a lucrative CAGR during the forecast period. The growth can be attributed to the rising number of intended and unintended pregnancies globally. As per the United Nations Population Fund, around 121 million pregnancies each year are unintended, which accounts for approximately 50% of overall pregnancies globally. The imaging systems, such as ultrasound, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and plain radiography, are utilized to investigate and determine potential harmful conditions in the pregnancy.

End-use Insights

On the basis of end-uses, the global industry has been further segmented into hospitals & clinics and Ambulatory Surgery Centers (ASCs). The hospitals & clinics segment dominated the industry in 2022 and accounted for the largest share of more than 64.85% of the overall revenue. The high share is mainly attributed to the increased demand for gynecological surgeries and the adoption of innovative technologies in hospitals & clinics. Advanced technologies are feasible surgical options and offer a better experience. For instance, in January 2022, The Women’s Hospital at Jackson Memorial, HCA Florida Healthcare’s Kendall Regional Medical Center, and AdventHealth Celebration started using the Hominis Surgical System, robotic surgical technology by Memic Innovative Surgery for gynecological procedures.

Global gynecological devices market share and size, 2022

The device provides minimally-invasive treatment options for gynecological surgeries and is U.S. FDA-authorized. The ASC end-use segment is projected to register the fastest growth rate during the forecast period. The growth of the segment can be attributed to the more affordable nature of these centers compared to other healthcare settings, such as hospitals and clinics. As per the Nationwide Ambulatory Surgery Sample (NASS) database, gynecological surgeries, such as hysterectomy, laparoscopic surgeries, oophorectomy, and others, were among the most common major ambulatory surgeries performed in younger females in the U.S. Around 419,000 major gynecological ambulatory surgeries were performed in the U.S. in 2019.

Regional Insights

North America dominated the global industry in 2022 and accounted for the maximum share of more than 38.4% of the overall revenue. It is expected to maintain its dominance throughout the forecast period owing to the presence of a well-established healthcare infrastructure, rising levels of awareness regarding the availability of diagnostic tests & treatments, and developed reimbursement coverage. According to the statistical brief published by the Healthcare Cost and Utilization Project, in 2019, around 419,000 hysterectomy, abdominal, and vaginal ambulatory surgeries were performed in the U.S., which accounts for 2.7% of the total ambulatory surgeries in 2019. Asia Pacific, on the other hand, is expected to witness the fastest growth rate during the forecast period.

Gynecological Devices Market Trends by Region, 2023 - 2030

The rising awareness regarding family planning and birth control due to government initiatives to control the growing population is expected to propel the product demand in the region. According to the United Nations Population Facts, in 2019, the need for modern contraceptives among women of reproductive age was around 90.1% and this is expected to remain constant till 2030. Moreover, China is among the countries having birth control policies. The rising prevalence of gynecological disorders coupled with rising surgical procedures is expected to foster the growth of the market in the region. For instance, as per an article published in the journal of Gynecology and Pelvic Medicine, in 2019, around 13,934 gynecological surgeries were performed in the Department of Gynecology, China.

Key Companies & Market Share Insights

This industry is highly fragmented with the presence of several local players. Thus, major companies practice merger and acquisition strategies to sustain competition and increase industry share. For instance, in October 2021, Hologic, Inc. entered into a definitive agreement for the acquisition of Bolder Surgical, a U.S.-based surgical devices company. The acquisition will contain laparoscopic dissecting, diving, and vessel sealing devices including Bolder’s CoolSeal, the JustRight 5 mm stapler, and JustRight 3 mm vessel sealer. Some of the key players in the global gynecological devices market include:

  • Medtronic plc

  • Cooper Surgical, Inc.

  • Richard Wolf GmbH

  • Hologic, Inc.

  • Boston Scientific Corp.

  • Stryker Corp.

  • Karl Storz GmbH & Co. KG

  • Ethicon, Inc. (Johnson & Johnson MedTech)

  • Cook Medical

  • Bayer AG

  • Gynemed

  • Gynex Corp.

Gynecological Devices Market Report Scope

Report Attribute

Details

Market size value in 2023

USD 10.1 billion

Revenue forecast in 2030

USD 18.1 billion

Growth rate

CAGR of 8.64% from 2023 to 2030

Base year for estimation

2022

Historical data

2017 - 2021

Forecast period

2023 - 2030

Quantitative units

Revenue in USD million/billion and CAGR from 2023 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product, end-use, region

Regional scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; Japan; China; India; Australia; South Korea; Mexico; Brazil; Argentina;South Africa; Saudi Arabia; UAE

Key companies profiled

Medtronic plc; Cooper Surgical, Inc.; Richard Wolf GmbH.; Hologic, Inc.; Boston Scientific Corp.; Stryker Corp.; Karl Storz GmbH & Co. KG; Ethicon, Inc., Cook Medical, Bayer AG, Gynemed, Gynex Corp.

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

 

Global Gynecological Devices Market Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For the purpose of this study, Grand View Research has segmented the global gynecological devices market report on the basis of product, end-use, and region:

Global Gynecological Devices Market Report Segmentation

  • Product Outlook (Revenue, USD Million, 2017 - 2030)

    • Surgical Devices

      • Gynecological Endoscopy Devices

        • Hysteroscope

        • Colposcope

        • Resectoscope

        • Laparoscope

      • Endoscopic imaging systems

        • Endometrial Ablation Devices

        • Hydrothermal Ablation Devices

        • Radiofrequency Ablation Devices

        • Balloon Ablation Devices

        • Others (Microwave, Laser)

      • Fluid Management Systems

      • Female Sterilization/Contraceptive Devices

        • Permanent Birth Control

        • Intra Uterine Devices (IUD)

        • Intravaginal rings

        • Subdermal Contraceptive Implants

    • Handheld Instruments

      • Vaginal Speculum

      • Tenaculum

      • Curettes

      • Trocars Market

      • Biopsy Forceps

      • Others

    • Diagnostic Imaging Systems

  • End-use Outlook (Revenue, USD Million, 2017 - 2030)

    • Hospital & Clinics

    • Ambulatory Surgery Centers (ASCs)

  • Regional Outlook (Revenue, USD Million, 2017 - 2030)

    • North America

      • U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

      • France

      • Italy

      • Spain

    • Asia Pacific

      • Japan

      • China

      • India

      • Australia

      • South Korea

    • Latin America

      • Mexico

      • Brazil

      • Argentina

    • Middle East & Africa (MEA)

      • South Africa

      • Saudi Arabia

      • UAE

Frequently Asked Questions About This Report

gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

Certified Icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.